Issue 12, 2003
From the journal:

Chemical Communications

Membrane activity of biotechnological peptidedrugs

Annika Malkia,a   Peter Liljerotha  and  Kyösti Kontturi*a  

* Corresponding authors

a Laboratory of Physical Chemistry and Electrochemistry, Helsinki University of Technology, PO Box 6100, Finland
E-mail: kontturi@cc.hut.fi
Fax: +358 9 451 2580
Tel: +358 9 451 2570

Abstract

Charged Langmuir–Blodgett monolayers deposited at an immobilised liquid–liquid interface have been used as a simple model for a biological membrane to investigate the membrane activity of biotechnological oligopeptide drugs.

Graphical abstract: Membrane activity of biotechnological peptide drugs

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/B300816A
Article type
Communication
Submitted
21 Jan 2003
Accepted
23 Apr 2003
First published
16 May 2003

Chem. Commun., 2003, 1430-1431

Permissions

Request permissions

Membrane activity of biotechnological peptide drugs

A. Malkia, P. Liljeroth and K. Kontturi, Chem. Commun., 2003, 1430 DOI: 10.1039/B300816A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements